Haematologica
(Nov 2024)
Incidental changes in hemoglobin levels in patients with myelofibrosis receiving treatment with sodium-glucose co-transporter-2 inhibitors
- Fnu Aperna,
- Ali K. Alsugair,
- Saubia Fathima,
- Ayalew Tefferi,
- Naseema Gangat
Affiliations
- Fnu Aperna
- Division of Hematology, Mayo Clinic, Rochester, MN
- Ali K. Alsugair
- Division of Hematology, Mayo Clinic, Rochester, MN
- Saubia Fathima
- Division of Hematology, Mayo Clinic, Rochester, MN
- Ayalew Tefferi
- Division of Hematology, Mayo Clinic, Rochester, MN
- Naseema Gangat
- Division of Hematology, Mayo Clinic, Rochester, MN
- DOI
-
https://doi.org/10.3324/haematol.2024.286867
- Journal volume & issue
-
Vol. 999,
no. 1
WeChat QR code